Effect of rosuvastatin on repeat heart failure hospitalizations: the corona trial (controlled rosuvastatin multinational trial in heart failure)

Effect of rosuvastatin on repeat heart failure hospitalizations: the corona trial (controlled rosuvastatin multinational trial in heart failure)

<p style="text-align:justify;"> <b>Objectives:</b> This study sought to examine the effect of statin therapy hospitalizations for heart failure (HFH) in patients in the CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure) trial.<br/><br/> <...

書誌詳細
主要な著者:	Rogers, J, Jhund, P, Perez, A, Böhm, M, Cleland, J, Gullestad, L, Kjekshus, J, Van Veldhuisen, D, Wikstrand, J, Wedel, H, McMurray, J, Pocock, S
フォーマット:	Journal article
言語:	English
出版事項:	Elsevier 2014

類似資料

Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
著者:: Erik Tandberg Askevold, 等
出版事項: (2015-01-01)

Rosuvastatin in older patients with systolic heart failure.
著者:: Florkowski, C, 等
出版事項: (2008)

Heart rate, heart rhythm and prognostic benefits of beta-blockers in heart failure: individual patient-data meta-analysis
著者:: Kotecha, D, 等
出版事項: (2017)

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
著者:: Cleland, J, 等
出版事項: (2017)

Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.
著者:: Gounari, P, 等
出版事項: (2010)

Rosuvastatin safety and efficacy in coronary heart disease patients
著者:: I. V. Sergienko, 等
出版事項: (2006-10-01)

Eplerenone in patients with systolic heart failure and mild symptoms
著者:: Rogers, J, 等
出版事項: (2012)

Acute renal failure due to rhabdomyolysis in relation to abiraterone and rosuvastatin
著者:: Melissa Cintra, 等
出版事項: (2023-05-01)

Comparative effects of rosuvastatin and allopurinol on circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with chronic heart failure.
著者:: Tousoulis, D, 等
出版事項: (2010)

Perioperative rosuvastatin in cardiac surgery
著者:: Zheng, Z, 等
出版事項: (2016)

Optimization of UPLC method for simultaneous determination of rosuvastatin and rosuvastatin degradation products
著者:: Jure Zakrajšek, 等
出版事項: (2017-12-01)

The Antimycotic Activity of Rosuvastatin
著者:: Zahraa Qasim
出版事項: (2022-12-01)

Current perspectives on rosuvastatin
著者:: Hu M, 等
出版事項: (2013-04-01)

WHETHER THE STUDY ON EFFICACY OF ROSUVASTATIN IN ELDERLY PATIENTS WITH HEART FAILURE AND SYSTOLIC DYSFUNCTION OF LEFT VENTRICLE HAD BEEN COMPLETED WITH “CROWNING”?
著者:: S. R. Gilyarevsky
出版事項: (2015-12-01)

WHETHER THE STUDY ON EFFICACY OF ROSUVASTATIN IN ELDERLY PATIENTS WITH HEART FAILURE AND SYSTOLIC DYSFUNCTION OF LEFT VENTRICLE HAD BEEN COMPLETED WITH “CROWNING”?
著者:: S. R. Gilyarevsky
出版事項: (2015-12-01)

Rosuvastatin-Induced reversible rhabdomyolysis
著者:: Sangeeta Pradhan, 等
出版事項: (2023-01-01)

Rosuvastatin induced photolocalized purpura
著者:: Marwa Thabouti, 等
出版事項: (2022-09-01)

Distinct effects of rosuvastatin and rosuvastatin/ezetimibe on senescence markers of CD8+ T cells in patients with type 2 diabetes mellitus: a randomized controlled trial
著者:: Sang-Hyeon Ju, 等
出版事項: (2024-03-01)

The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences
著者:: Venkata Narla, 等
出版事項: (2009-11-01)

The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial.
著者:: Kaspar Broch, 等
出版事項: (2014-01-01)

The year in cardiology: heart failure. The year in cardiology 2019
著者:: J.G.F. Cleland, 等
出版事項: (2020-04-01)

THE CONCERNS OF ROSUVASTATIN CLINICAL EFFICACY AND SAFETY
著者:: V. V. Kukharchuk, 等
出版事項: (2013-06-01)

The influence of the intestinal microflora to the efficacy of Rosuvastatin
著者:: Lijun Wang, 等
出版事項: (2018-06-01)

Reducing cardiovascular risk: an emphasis on rosuvastatin
著者:: Anikin G.S., 等
出版事項: (2017-11-01)

Analysis of genetic aspects of therapy with Rosuvastatin
著者:: Samat Kozhakhmetov, 等
出版事項: (2016-06-01)

Preparation and optimization of microemulsion of rosuvastatin calcium
著者:: B Zalak Patel, 等
出版事項: (2012-01-01)

Efficacy and safety of rosuvastatin in the management of dyslipidemia
著者:: Paolo Rubba, 等
出版事項: (2009-04-01)

Debate: Statins should be used in patients with heart failure
著者:: Kjekshus John
出版事項: (2001-11-01)

Efficacy of Combination Therapy of Rosuvastatin and Ezetimibe vs Rosuvastatin Monotherapy on Lipid Profile of Patients with Coronary Artery Disease
著者:: Sandeep Joshi, 等
出版事項: (2017-12-01)

Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales
著者:: Emdin, C, 等
出版事項: (2016)

Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction. A report from the Irbesartan in Heart Failure with Preserved Ejection Fraction trial (I-Preserve)
著者:: Kristensen, S, 等
出版事項: (2017)

Rethinking heart failure clinical trials: the heart failure collaboratory
著者:: Mutaz Alkalbani, 等
出版事項: (2024-01-01)

P5.04 EFFECT OF ROSUVASTATIN ON THE ECHOLUCENCY OF THE COMMON CAROTID INTIMA–MEDIA THICKNESS: THE METEOR TRIAL
著者:: L. Lind, 等
出版事項: (2011-11-01)

Characteristics of heart failure managed in primary care in Europe: the IMPROVEMENT of heart failure survey
著者:: Cleland, J, 等
出版事項: (2001)

2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.
著者:: Dickstein, K, 等
出版事項: (2010)

2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.
著者:: Dickstein, K, 等
出版事項: (2010)

Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis
著者:: Kotecha, D, 等
出版事項: (2016)

Determination of a “Specific Population Who Could Benefit From Rosuvastatin”: A Secondary Analysis of a Randomized Controlled Trial to Uncover the Novel Value of Rosuvastatin for the Precise Treatment of ARDS
著者:: Shi Zhang, 等
出版事項: (2020-11-01)

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM‐Preserved
著者:: Rogers, J, 等
出版事項: (2013)

Perioperative rosuvastatin in cardiac surgery - Author's reply
著者:: Casadei, B, 等
出版事項: (2016)